Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
- 24 March 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 52 (6), 889-894
- https://doi.org/10.1016/j.jhep.2009.12.041
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005Journal of Clinical Oncology, 2009
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Long-Term Interferon Maintenance Therapy Improves Survival in Patients with HCV-Related Hepatocellular Carcinoma after Curative Radiofrequency AblationOncology, 2007
- A Randomized, Controlled Trial of Postoperative Adjuvant Interferon Therapy After Resection of Hepatocellular CarcinomaAnnals of Surgery, 2007
- Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosisHepatology, 2006
- Postoperative interferon α treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trialZeitschrift für Krebsforschung und Klinische Onkologie, 2006
- Changing disease burden of hepatocellular carcinoma in the Far East and Southeast AsiaLiver International, 2005
- Treatment of hepatitis C: critical appraisal of the evidenceExpert Opinion on Pharmacotherapy, 2005
- Diagnosis, management, and treatment of hepatitis CHepatology, 2004
- Surgical treatment of hepatocellular carcinoma: Similar long-term results despite geographic variationsLiver Transplantation, 2004